RT Journal Article
SR Electronic
T1 Healthcare workers hospitalized due to COVID-19 have no higher risk of death than general population. Data from the Spanish SEMI-COVID-19 Registry
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.23.20236810
DO 10.1101/2020.11.23.20236810
A1 Jesús Díez-Manglano
A1 Marta Nataya Solís Marquínez
A1 Andrea Álvarez García
A1 Nicolás Alcalá-Rivera
A1 Irene Maderuelo Riesco
A1 Martín Gericó Aseguinolaza
A1 José Luis Beato Pérez
A1 Manuel Mendez Bailon
A1 Ane Elbire Labirua-Iturburu Ruiz
A1 Miriam García Gómez
A1 Carmen Martinez Cilleros
A1 Paula Maria Pesqueira Fontan
A1 Lucy Abella Vázquez
A1 Julio César Blázquez Encinar
A1 Ramon Boixeda
A1 Ricardo Gil Sánchez
A1 Andrés de la Peña Fernández
A1 Jose Loureiro Amigo
A1 Joaquin Escobar Sevilla
A1 Marcos Guzmán Garcia
A1 María Dolores Martín Escalante
A1 Jeffrey Oskar Magallanes Gamboa
A1 Angel Luís Martínez Gonzalez
A1 Carlos Lumbreras Bermejo
A1 Juan Miguel Antón Santos
A1 for the SEMI-COVID-19 Network
YR 2020
UL http://medrxiv.org/content/early/2020/11/24/2020.11.23.20236810.abstract
AB Aim To determine whether healthcare workers (HCW) hospitalized in Spain due to COVID-19 have a worse prognosis than non-healthcare workers (NHCW).Methods Observational cohort study based on the SEMI-COVID-19 Registry, a nationwide registry that collects sociodemographic, clinical, laboratory, and treatment data on patients hospitalised with COVID-19 in Spain. Patients aged 20-65 years were selected. A multivariate logistic regression model was performed to identify factors associated with mortality.Results As of 22 May 2020, 4393 patients were included, of whom 419 (9.5%) were HCW. Median (interquartile range) age of HCW was 52 (15) years and 62.4% were women. Prevalence of comorbidities and severe radiological findings upon admission were less frequent in HCW. There were no difference in need of respiratory support and admission to intensive care unit, but occurrence of sepsis and in-hospital mortality was lower in HCW (1.7% vs. 3.9%; p=0.024 and 0.7% vs. 4.8%; p<0.001 respectively). Age, male sex and comorbidity, were independently associated with higher in-hospital mortality and healthcare working with lower mortality (OR 0.219, 95%CI 0.069-0.693, p=0.01). 30-days survival was higher in HCW (0.968 vs. 0.851 p<0.001).Conclusions Hospitalized COVID-19 HCW had fewer comorbidities and a better prognosis than NHCW. Our results suggest that professional exposure to COVID-19 in HCW does not carry more clinical severity nor mortality.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research received no external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was carried out in accordance with the Declaration of Helsinki. The processing of personal data strictly complied with Spanish Law 14/2007, of July 3, on Biomedical Research and Spanish Organic Law 3/2018, of 5 December, on the Protection of Personal Data and the Guarantee of Digital Rights.The study was approved by the Provincial Research Ethics Committee of Malaga (Spain) following the recommendation of the Spanish Agency of Medicines and Medical Products (AEMPS, for its initials in Spanish).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe used data of the SEMI-COVID-19-Registry, which has been previously described (Casas JM. Rev Clin Esp 2020; 220: 480-94). Due to legal issues, some restrictions apply to our data and they cannot be uploaded to any public server. However, we can share the data as a request to the Principal Investigator of the EpiChron Cohort Study at covid-gestion@reginus.es.